ViraBiotech

ViraBiotech is a biotechnology company based in Tehran, Iran, specializing in the development and production of high-tech biological products, including vaccines and recombinant proteins. The company is best known for developing ViraPap, a quadrivalent human papillomavirus (HPV) vaccine designed to prevent cervical cancer and other HPV-related diseases. Beyond its flagship vaccine, ViraBiotech's portfolio includes diagnostic kits and research into other viral vaccines, such as those for Hepatitis B and COVID-19. The company operates GMP-certified manufacturing facilities and focuses on providing affordable, high-quality biopharmaceuticals to the Middle Eastern market. Their work integrates advanced recombinant DNA technology and virus-like particle platforms to address significant public health challenges.